AAAAAA

   
Results: 1-11 |
Results: 11
Recombinant factor IX (BeneFix (R)) by adjusted continuous infusion: a study of stability, sterility and clinical experience
Authors: Chowdary, P Dasani, H Jones, JAH Loran, CM Eldridge, A Hughes, S Collins, PW
Citation: P. Chowdary et al., Recombinant factor IX (BeneFix (R)) by adjusted continuous infusion: a study of stability, sterility and clinical experience, HAEMOPHILIA, 7(2), 2001, pp. 140-145
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding
Authors: Smith, MP Ludlam, CA Collins, PW Hay, CRM Wilde, JT Grigeri, A Melsen, T Savidge, GF
Citation: Mp. Smith et al., Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding, THROMB HAEM, 86(4), 2001, pp. 949-953
High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated?
Authors: Bowen, DJ Maclean, RM Pellard, S Collins, PW
Citation: Dj. Bowen et al., High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated?, BR J HAEM, 113(3), 2001, pp. 655-657
Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor
Authors: Hilbert, L Jenkins, PV Gaucher, C Meriane, E Collins, PW Pasi, KJ Mazurier, C
Citation: L. Hilbert et al., Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor, THROMB HAEM, 84(2), 2000, pp. 188-194
Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents
Authors: Khanna, IK Yu, Y Huff, RM Weier, RM Xu, XD Koszyk, FJ Collins, PW Cogburn, JN Isakson, PC Koboldt, CM Masferrer, JL Perkins, WE Seibert, K Veenhuizen, AW Yuan, JH Yang, DC Zhang, YY
Citation: Ik. Khanna et al., Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents, J MED CHEM, 43(16), 2000, pp. 3168-3185
Faunal remains in California Condor nest caves
Authors: Collins, PW Snyder, NFR Emslie, SD
Citation: Pw. Collins et al., Faunal remains in California Condor nest caves, CONDOR, 102(1), 2000, pp. 222-227
A new polymorphism in the human factor VIII gene: implications for linkageanalysis in haemophilia A and for the evolution of int22h sequences
Authors: Bowen, DJ De Brasi, CD Larripa, IB Collins, PW
Citation: Dj. Bowen et al., A new polymorphism in the human factor VIII gene: implications for linkageanalysis in haemophilia A and for the evolution of int22h sequences, BR J HAEM, 111(2), 2000, pp. 544-548
The diagnosis and management of factor VIII and IX inhibitors: A guidelinefrom the UK Haemophilia Centre Doctors' Organization (UKHCDO)
Authors: Hay, CRM Baglin, TP Collins, PW Hill, FGH Keeling, DM
Citation: Crm. Hay et al., The diagnosis and management of factor VIII and IX inhibitors: A guidelinefrom the UK Haemophilia Centre Doctors' Organization (UKHCDO), BR J HAEM, 111(1), 2000, pp. 78-90
Specific analysis of the intron 22 XbaI polymorphism of the human factor VIII gene using long-distance PCR
Authors: De Brasi, CD Bowen, DJ Collins, PW Larripa, IB
Citation: Cd. De Brasi et al., Specific analysis of the intron 22 XbaI polymorphism of the human factor VIII gene using long-distance PCR, BR J HAEM, 107(3), 1999, pp. 566-568
Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
Authors: MacLean, RM Feeney, GP Bowley, SJ Bowen, DJ Worwood, M Collins, PW
Citation: Rm. Maclean et al., Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?, BR J HAEM, 107(1), 1999, pp. 210-212
Antiinflammatory 4,5-diarylimidazoles as selective cyclooxygenase inhibitors
Authors: Barta, TE Stealey, MA Collins, PW Weier, RM
Citation: Te. Barta et al., Antiinflammatory 4,5-diarylimidazoles as selective cyclooxygenase inhibitors, BIOORG MED, 8(24), 1998, pp. 3443-3448
Risultati: 1-11 |